Mogamulizumab‐Associated Autoimmune Diseases: Insights From <scp>FAERS</scp> Database Analysis
This study replicated previously identified AEs associated with mogamulizumab and uncovered additional signals of AEs, particularly emphasizing the risks associated with autoimmune diseases. It is essential to exercise vigilance in monitoring the occurrence of these AEs during the use of mogamulizumab in clinical practice.
Authors
- Genshan Zhang (ORCID: https://orcid.org/0009-0000-2545-0612)
- Zhixin Cao (ORCID: https://orcid.org/0009-0008-5170-2340)
- Jie Fu (ORCID: https://orcid.org/0000-0003-2608-1147)
- Haokun Zhang
Institutions
- Gannan Medical University (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/cam4.70478
- Citations
- 2
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.88
Funders
- CIEE Ping Foundation
- Huazhong University of Science and Technology
- Tongji University
- Nanchang University
- Tongji Medical College, Huazhong University of Science and Technology